1.495
전일 마감가:
$1.55
열려 있는:
$1.55
하루 거래량:
37,568
Relative Volume:
0.01
시가총액:
$6.44M
수익:
$960.60K
순이익/손실:
$-7.10M
주가수익비율:
-0.1978
EPS:
-7.56
순현금흐름:
$-8.00M
1주 성능:
-3.85%
1개월 성능:
+8.70%
6개월 성능:
-22.04%
1년 성능:
-61.14%
Soligenix Inc Stock (SNGX) Company Profile
명칭
Soligenix Inc
전화
609-538-8200
주소
29 EMMONS DRIVE, PRINCETON
SNGX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SNGX
Soligenix Inc
|
1.5036 | 12.97M | 960.60K | -7.10M | -8.00M | -7.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.74 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.57 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.54 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.00 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Soligenix Inc Stock (SNGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-07-28 | 다운그레이드 | Dawson James | Buy → Neutral |
| 2018-01-31 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2017-08-14 | 재확인 | Maxim Group | Buy |
| 2017-07-17 | 개시 | H.C. Wainwright | Buy |
Soligenix Inc 주식(SNGX)의 최신 뉴스
Will Soligenix Inc. stock benefit from infrastructure spendingJobs Report & Free AI Powered Buy and Sell Recommendations - newser.com
Is Soligenix Inc. (DOA) stock in buy zone after pullbackForecast Cut & AI Driven Stock Movement Reports - newser.com
How Soligenix Inc. (DOA) stock compares with tech leaders2025 Volume Leaders & Low Drawdown Momentum Trade Ideas - newser.com
Is Soligenix Inc. (DOA) stock good for long term investingJuly 2025 Drop Watch & Comprehensive Market Scan Insights - newser.com
Why Soligenix Inc. (DOA0) stock stays on top picks2025 Breakouts & Breakdowns & Weekly High Potential Stock Alerts - newser.com
Can Soligenix Inc. stock deliver sustainable ROE2025 Technical Patterns & Risk Adjusted Swing Trade Ideas - newser.com
Will Soligenix Inc. (DOA) stock maintain strong growthJuly 2025 Levels & Safe Capital Investment Plans - newser.com
Is Soligenix Inc. (DOA) stock a momentum leaderEarnings Overview Summary & Weekly Sector Rotation Insights - newser.com
What sentiment indicators say about Soligenix Inc. stockMarket Sentiment Report & Daily Profit Focused Screening - newser.com
Visual analytics tools that track Soligenix Inc. performanceWall Street Watch & Safe Capital Growth Tips - newser.com
Why Soligenix Inc. (DOA0) stock is trending on social mediaJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Will Soligenix Inc. (DOA0) stock top growth indexesEarnings Overview Summary & Weekly Breakout Stock Alerts - newser.com
Will Soligenix Inc. stock gain from government policiesJuly 2025 Review & AI Enhanced Trade Execution Alerts - newser.com
Is Soligenix Inc. stock a buy in volatile marketsJuly 2025 Setups & Technical Pattern Based Buy Signals - newser.com
Is Soligenix Inc. trending in predictive chart modelsJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - newser.com
Applying Wyckoff theory to Soligenix Inc. stockJuly 2025 Outlook & High Accuracy Trade Alerts - newser.com
Published on: 2025-11-01 03:35:33 - newser.com
Is Soligenix Inc. stock attractive for income investors2025 Growth vs Value & Smart Allocation Stock Reports - newser.com
Is Soligenix Inc. stock a buy on dipsMarket Trend Review & Free Daily Entry Point Trade Alerts - newser.com
Published on: 2025-10-31 04:43:24 - newser.com
Understanding Soligenix Inc.’s price movementWeekly Trading Summary & AI Forecast Swing Trade Picks - newser.com
Soligenix’s Promising Phase 2 Study on SGX302 for Psoriasis: A Potential Game-Changer - TipRanks
Soligenix’s Phase 3 Study on HyBryte™: A Potential Game-Changer for CTCL Treatment - MSN
Published on: 2025-10-30 06:40:41 - newser.com
Published on: 2025-10-30 04:26:59 - newser.com
Why Soligenix Inc. stock could outperform in 20252025 Institutional Moves & Verified Swing Trading Watchlists - newser.com
Soligenix Inc (SNGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):